p21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts

Molecular Biology of the Cell

Volumn 18, Issue 12, 2007, Pages 4837-4846

  Roy, Sashwati ^a   Khanna, Savita ^a   Rink, Trenton ^a   Radtke, Jared ^a   Williams, W Taylor ^a   Biswas, Sabyasachi ^a   Schnitt, Rebecca ^a   Strauch, Arthur R ^a   Sen, Chandan K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; SMOOTH MUSCLE ACTIN; ACTIN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; HYPEROXIA; IN VIVO STUDY; ISCHEMIA; LASER; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART MUSCLE; METABOLISM; SMOOTH MUSCLE;

MUS;

ACTINS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FIBROBLASTS; GENE EXPRESSION REGULATION; HEART; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH; MYOCARDIUM; OXYGEN; RNA, MESSENGER;

EID: 37049008897     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-03-0270     Document Type: Article

References (50)

1. Bachman, K. E., Blair, B. G., Brenner, K., Bardelli, A., Arena, S., Zhou, S., Hicks, J., De Marzo, A. M., Argani, P., and Park, B. H. (2004). p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells. Cancer Biol. Ther. 3, 221-225.
2. Borer, J. S., Truter, S., Herrold, E. M., Falcone, D. J., Pena, M., Carter, J. N., Dumlao, T. F., Lee, J. A., and Supino, P. G. (2002). Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload. Circulation 105, 1837-1842.
3. Brilla, C. G. (2000). Renin-angiotensin system mediated mechanisms: cardioreparation and cardioprotection. Heart 84(Suppl 1), i18-i19, discussion, i50.
4. Brown, R. D., Ambler, S. K., Mitchell, M. D., and Long, C. S. (2005). The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 45, 657-687.
5. Bujak, M., and Frangogiannis, N. G. (2007). The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 74, 184-195.
6. Burlew, B. S., and Weber, K. T. (2002). Cardiac fibrosis as a cause of diastolic dysfunction. Herz 27, 92-98.
7. Capasso, J. M., Palackal, T., Olivetti, G., and Anversa, P. (1990). Severe myocardial dysfunction induced by ventricular remodeling in aging rat hearts. Am. J. Physiol. 259, H1086-H1096.
8. Coqueret, O. (2003). New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13, 65-70.
9. Corroyer, S., Maitre, B., Cazals, V., and Clement, A. (1996). Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes. J. Biol. Chem. 271, 25117-25125.
10. Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., and Sorescu, D. (2005). NAD(P)H oxidase 4 mediates transforming growth factor-betal-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97, 900-907.
11. Desmouliere, A., Chaponnier, C., and Gabbiani, G. (2005). Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 13, 7-12.
12. Eghbali, M., Czaja, M. J., Zeydel, M., Weiner, F. R., Zern, M. A., Seifter, S., and Blumenfeld, O. O. (1988). Collagen chain mRNAs in isolated heart cells from young and adult rats. J. Mol. Cell. Cardiol. 20, 267-276.
13. Foster, D. N., Min, B., Foster, L. K., Stoflet, E. S., Sun, S., Getz, M. J., and Strauch, A. R. (1992). Positive and negative cis-acting regulatory elements mediate expression of the mouse vascular smooth muscle alpha-actin gene. J. Biol. Chem. 267, 11995-12003.
14. Frangogiannis, N. G. (2006). The mechanistic basis of infarct healing. Antioxid. Redox Signal. 8, 1907-1939.
15. Frangogiannis, N. G., Michael, L. H., and Entman, M. L. (2000). Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle iryosin heavy chain (SMemb). Cardiovasc Res. 48, 89-100.
16. Hinz, B., Mastrangelo, D., Iselin, C. E., Chaponnier, C., and Gabbiani, G. (2001). Mechanical tension controls granulation tissue contractile activity and myofibroblast difi:erentiation. Am. J. Pathol. 159, 1009-1020.
17. Kelm, R. J., Jr., Cogan, J. G., Elder, P. K., Strauch, A. R., and Getz, M. J. (1999). Molecular interactions between single-stranded DNA-binding proteins associated with an essential MCAT element in the mouse smooth muscle alpha-actin promoter. J. Biol. Chem. 274, 14238-14245.
18. Khanna, S., Roy, S., Maurer, M., Ratan, R. R., and Sen, C. K. (2006). Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: Prolyl hydroxylases tune the biological normoxic set point. Free Radic Biol. Med. 40, 2147-2154.
19. Krishan, A. (1975). Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66, 188-193.
20. Kuhn, D., Roy, S., Radtke, J., Khanna, S., and Sen, C. K. (2007). Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyperoxia induces P21 in peri-infarct myocytes. Am. J. Physiol. Heart Circ. Physiol. 292, H1245-H1253.
21. Kuhn, D. E., Roy, S., Radtke, J., Gupta, S., and Sen, C. K. (2006). Laser microdissection and pressure-catapulting technique to study gene expression in the reoxygenated myocardium. Am. J. Physiol. Heart Circ. Physiol. 290, H2625-H2632.
22. Kumar, R., Gururaj, A. E., and Barnes, C. J. (2006). p21-activated kinases in cancer. Nat. Rev. Cancer 6, 459-471.
23. Laframboise, W. A., Scalise, D., Stoodley, P., Graner, S., Guthrie, R. D., Magovern, J., and Becich, M. (2007). Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am. J. Physiol. Cell Physiol. 292(5), C1799-C1808.
24. Li, C. Y., Suardet, L., and Little, J. B. (1995). Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J. Biol. Chem. 270, 4971-4974.
25. Liao, X. D., Wang, X. H., Jin, H. J., Chen, L. Y., and Chen, Q. (2004). Mechanical stretch induces mitochondria-dependent apoptosis in neonatal rat cardiomyocytes and G2/M accumulation in cardiac fibroblasts. Cell Res. 14, 16-26.
26. Manapov, F., Muller, P., and Rychly, J. (2005). Translocation of p21(Cip1/WAF1) from the nucleus to the cytoplasm correlates with pancreatic myofibroblast to fibroblast cell conversion. Gut 54, 814-822.
27. Min, B. H., Foster, D. N., and Strauch, A. R. (1990). The 5′-flanking region of the mouse vascular smooth muscle alpha-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J. Biol. Chem. 265, 16667-16675.
28. Miragoli, M., Gaudesius, G., and Rohr, S. (2006). Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ. Res. 98, 801-810.
29. Nabel, E. G. (2002). CDKs and CKIs: molecular targets for tissue remodelling. Nature Rev. Drug Disc. 1, 587-598.
30. Naugle, J. E., Olson, E. R., Zhang, X., Mase, S. E., Pilati, C. F., Maron, M. B., Folkesson, H. G., Horne, W. I., Doane, K. J., and Meszaros, J. G. (2006). Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am. J. Physiol. Heart Circ. Physiol. 290, H323-H330.
31. O'Reilly, M. A., Staversky, R. J., Watkins, R. H., Reed, C. K., de Mesy Jensen, K. L., Finkelstein, J. N., and Keng, P. C. (2001). The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am. J. Respir Cell. Mol. Biol. 24, 703-710.
32. Okamoto, T., Izumi, H., Imamura, T., Takano, H., Ise, T., Uchiumi, T., Kuwano, M., and Kohno, K. (2000). Direct interaction of p53 with the Y-box binding protein, YB-1, a mechanism for regulation of human gene expression. Oncogene 19, 6194-6202.
33. Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., and West, A. B. (1999). Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C9.
34. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. (1995). Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9, 1831-1845.
35. Roy, S. et al. (2003a). Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ. Res. 92, 264-271.
36. Roy, S., Khanna, S., Kuhn, D. E., Rink, C., Williams, W. T., Zweier, J. L., and Sen, C. K. (2006a). Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol. Genomics 25, 364-374.
37. Roy, S., Khanna, S., Nallu, K., Hunt, T. K., and Sen, C. K. (2006b). Dermal wound healing is subject to redox control. Mol. Ther. 13, 211-220.
38. Roy, S., Khanna, S., Wallace, W. A., Lappalainen, J., Rink, C., Cardounel, A. J., Zweier, J. L., and Sen, C. K. (2003b). Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J. Biol. Chem. 278, 47129-47135.
39. Sen, C. K., Khanna, S., and Roy, S. (2006). Perceived hyperoxia: oxygen-induced remodeling of the reoxygenated heart. Cardiovasc. Res. 71, 280-288.
40. Serini, G., and Gabbiani, G. (1999). Mechanisms of myofibroblast activity and phenotypic modulation. Exp. Cell Res. 250, 273-283.
41. Siaghy, E. M., Devaux, Y., Sfaksi, N., Carteaux, J. P., Ungureanu-Longrois, D., Zannad, F., Villemot, J. P., Burlet, C., and Mertes, P. M. (2000). Consequences of inspired oxygen fraction manipulation on myocardial oxygen pressure, adenosine and lactate concentrations: a combined myocardial microdialysis and sensitive oxygen electrode study in pigs. J. Mol. Cell. Cardiol. 32, 493-504.
42. Staversky, R. J., Watkins, R. H., Wright, T. W., Hernady, E., LoMonaco, M. B., D'Angio, C. T., Williams, J. P., Maniscalco, W. M., and O'Reilly, M. A. (2002). Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1). Am. J. Pathol. 161, 1383-1393.
43. Sun, Y., Zhang, J. Q., Zhang, J., and Lamparter, S. (2000). Cardiac remodeling by fibrous tissue after infarction in rats. J. Lab. Clin. Med. 135, 316-323.
44. Swaney, J. S., Roth, D. M., Olson, E. R., Naugle, J. E., Meszaros, J. G., and Insel, P. A. (2005). Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc. Natl. Acad. Sci. USA 102, 437-442.
45. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., and Brown, R. A. (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3, 349-363.
46. Wada, T., Pippin, J. W., Terada, Y., and Shankland, S. J. (2005). The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis. Kidney Int. 68, 1618-1629.
47. Weber, K. T., and Brilla, C. G. (1991). Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83, 1849-1865.
48. Weiss, R. H., and Randour, C. J. (2002). Attenuation of matrix protein secretion by antisense oligodeoxynucleotides to the cyclin kinase inhibitor p21(Waf1/Cip1). Atherosclerosis 161, 105-112.
49. Zhang, A., Liu, X., Cogan, J. G., Fuerst, M. D., Polikandriotis, J. A., Keim, R. J., Jr., and Strauch, A. R. (2005). YB-1 coordinates vascular smooth muscle alpha-actin gene activation by transforming growth factor beta1 and thrombin during differentiation of human pulmonary myofibroblasts. Mol. Biol. Cell 16, 4931-4940.
50. Zhang, X., Azhar, G., Nagano, K., and Wei, J. Y. (2001). Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J. Am. Coll. Cardiol. 38, 2055-2062.